TIM3 expression on tumor cells predicts response to anti-PD-1 therapy for renal cancer

TIM3 expression on tumor cells predicts response to anti-PD-1 therapy for renal cancer

This study aimed to identify novel prognostic biomarker for advanced renal cell carcinoma (RCC) patients treated with anti-PD-1 therapy, using quantitative multi-immunofluorescence (IF) analysis of tumor immunity. Twenty-five consecutive patients who had metastatic or unresectable RCC treated with a...

Full description

Bibliographic Details
Main Authors: Renpei Kato, Noriaki Jinnouchi, Takashi Tuyukubo, Daiki Ikarashi, Tomohiko Matsuura, Shigekatsu Maekawa, Yoichiro Kato, Mitsugu Kanehira, Ryo Takata, Kazuyuki Ishida, Wataru Obara
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Translational Oncology
Subjects:
TIM3
Renal cancer
Anti-PD-1 therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523320304101

Internet

http://www.sciencedirect.com/science/article/pii/S1936523320304101

Similar Items